Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMYD2 | Q9NRG4 | 3/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | DUT | P33316 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29142571 | 0.93 | SMYD2 (0.37) | SMYD2CYP3A4HTTSMN1; SMN2 | |
| SCHEMBL28550615 | 0.88 | SMYD2 (0.40) | SMYD2CYP3A4HTTSMN1; SMN2 | |
| SCHEMBL702653 | 0.84 | LTA4H (0.42) | SMYD2CYP3A4HTTSMN1; SMN2 | |
| SCHEMBL2508018 | 0.84 | SMYD2 (0.39) | SMYD2CYP3A4HTTSMN1; SMN2DUT | |
| SCHEMBL24312364 | 0.83 | SMN1; SMN2 (0.40) | SMYD2CYP3A4HTTSMN1; SMN2 | |
| SCHEMBL4266551 | 0.83 | SMYD2 (0.38) | SMYD2CYP3A4HTTSMN1; SMN2DUT | |
| SCHEMBL5488886 | 0.83 | LTA4H (0.42) | SMYD2CYP3A4HTTSMN1; SMN2 | |
| SCHEMBL440160 | 0.83 | SMYD2 (0.38) | SMYD2CYP3A4HTTSMN1; SMN2 | |
| SCHEMBL2818126 | 0.83 | SMN1; SMN2 (0.38) | SMYD2CYP3A4HTTSMN1; SMN2 | |
| SCHEMBL6446538 | 0.83 | SMYD2 (0.38) | SMYD2CYP3A4HTTSMN1; SMN2DUT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230373900-A1 | CYCLOPROPENIUM COMPOUNDS, PROCESS FOR THEIR PREPARATION AND USE | FUNDACIÓ INSTITUT CATALÀ D'INVESTIGACIÓ QUÍMICA (ES) | 2023-11-23 | — | — | US | claimed |
| EP-4279480-A1 | CYCLOPROPENIUM COMPOUNDS, PROCESS FOR THEIR PREPARATION AND USE | Fundació Institut Català d'Investigació Química (ES) | 2023-11-22 | — | — | EP | claimed |
| US-20230373900-A1 | CYCLOPROPENIUM COMPOUNDS, PROCESS FOR THEIR PREPARATION AND USE | FUNDACIÓ INSTITUT CATALÀ D'INVESTIGACIÓ QUÍMICA (ES) | 2023-11-23 | — | — | US | disclosed |
| EP-4279480-A1 | CYCLOPROPENIUM COMPOUNDS, PROCESS FOR THEIR PREPARATION AND USE | Fundació Institut Català d'Investigació Química (ES) | 2023-11-22 | — | — | EP | disclosed |
| CN-109641931-B | Method for synthesizing ribonucleic acid H-phosphate monomer and oligonucleotide synthesis using the same | 基因设计有限公司 | 2022-10-18 | — | — | CN | disclosed |
| US-11174279-B2 | Method for synthesizing ribonucleic acid H-phosphonate monomer, and oligonucleotide synthesis in which said monomer is used | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2021-11-16 | — | — | US | disclosed |
| US-20200331945-A1 | METHOD FOR SYNTHESIZING RIBONUCLEIC ACID H-PHOSPHONATE MONOMER, AND OLIGONUCLEOTIDE SYNTHESIS IN WHICH SAID MONOMER IS USED | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2020-10-22 | — | — | US | disclosed |
| EP-3473637-A1 | METHOD FOR SYNTHESIZING RIBONUCLEIC ACID H-PHOSPHONATE MONOMER, AND OLIGONUCLEOTIDE SYNTHESIS IN WHICH SAID MONOMER IS USED | Genedesign, Inc. (JP) | 2019-04-24 | — | — | EP | disclosed |
| US-7125999-B2 | Process for producing organotitanium compound and process for addition reaction | NISSAN CHEMICAL INDUSTIES, LTD. (JP) | 2006-10-24 | — | — | US | disclosed |
| US-20040167344-A1 | Process for producing organotitanium compound and process for addition reaction | FUMIE SATO | 2004-08-26 | — | — | US | disclosed |
| US-6743916-B2 | REACTING AN ACETYLENE COMPOUND IN THE PRESENCE OF A TITANIUM COMPOUND AND GRIGNARD REAGENT TO OBTAIN ORGANOTITANIUM COMPOUND | Sato, Fumie (JP) | 2004-06-01 | — | — | US | disclosed |
| US-20030096996-A1 | Process for producing organotitanium compound and process for addition reaction | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2003-05-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040167344-A1 | Process for producing organotitanium compound and process for addition reaction | ZYX, H1-4, GRIA4 | SMYD2 3137/4885CYP3A4 64/4885HTT 3944/4885 |
| US-20200331945-A1 | METHOD FOR SYNTHESIZING RIBONUCLEIC ACID H-PHOSPHONATE MONOMER, AND OLIGONUCLEOTIDE SYNTHESIS IN WHICH SAID MONOMER IS USED | RNGTT, RNASEL, NSUN3 | SMYD2 1177/4885CYP3A4 4085/4885HTT 371/4885 |
| US-20030096996-A1 | Process for producing organotitanium compound and process for addition reaction | ZYX, H1-4, GRIA4 | SMYD2 3137/4885CYP3A4 64/4885HTT 3944/4885 |
| US-11174279-B2 | Method for synthesizing ribonucleic acid H-phosphonate monomer, and oligonucleotide synthesis in which said monomer is used | RNGTT, RNASEL, NSUN3 | SMYD2 1177/4885CYP3A4 4085/4885HTT 371/4885 |
| US-20230373900-A1 | CYCLOPROPENIUM COMPOUNDS, PROCESS FOR THEIR PREPARATION AND USE | DHPS, CYP11B2, PIN1 | SMYD2 1210/4885CYP3A4 22/4885HTT 1719/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.